HHS, DOD collaborate with Merck to continue the development and large-scale manufacturing of investigational COVID-19 treatment

Date Published12/23/2020
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Merck
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2020
Year reshoring implemented or to be implemented:2020
Domestically, the work will be done:In-house
Capital investment ($):356
City reshored to:Kenilworth
State(s) reshored to:NJ
If relevant, work nearshored to:-
Product(s) reshoredtherapeutic MK-7110
What domestic positive factors made reshoring more attractive?Government Incentives
Government Incentive dollar amount:$356 million
Find Reshoring Articles